Jci_page_head_homepage_01 Jci_page_head_homepage_02
Ann Marie Schmidt, Shi Du Yan, Shi Fang Yan, David M. Stern
Published in Volume 108, Issue 7
J Clin Invest. 2001; 108(7):949–955 doi:10.1172/JCI14002
Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 3

Schematic depiction of a role for receptor-mediated interaction with pathogenic Aβ assemblies (which could be dimers, multimers, and/or fibrils) in mediating cellular dysfunction early in amyloidoses (left). In contrast, nonspecific neuronal/cellular toxicity (for example, interfering with the integrity of cell membranes) is likely to be an important mechanism of cellular injury at later stages of the disease when there is a higher level of Aβ (right).